Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in Relapsing Multiple Sclerosis
NCT01487096Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2001
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Apr 2001; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01487096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487096.